Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure

Joann J. Kang, Jose De La Cruz, Maria Soledad Cortina

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Purpose: To report the short-term visual outcomes and complications of keratoprosthesis surgery as the primary penetrating corneal procedure for patients at high risk for conventional corneal transplantation. Methods: A retrospective chart review was conducted of 21 eyes of 19 patients who underwent either Boston keratoprosthesis type I or type II as the primary penetrating corneal procedure from February 2007 to March 2011. Results: Nineteen type I (90.5%) and 2 type II (9.5%) Boston keratoprosthesis procedures were performed in 19 patients. Mean follow-up was 14.6 months (range, 6-36.3 mo). Primary indications for surgery included chemical or thermal injury, aniridia, and Stevens-Johnson syndrome. Preoperative best-corrected visual acuity (BCVA) ranged from 20/100 to light perception and was count fingers or worse in 20 eyes (95.2%). At last follow-up for all eyes, 15 eyes (71.4%) achieved BCVA ≥ 20/200 and 4 eyes (19%) improved to BCVA ≥ 20/50. No intraoperative complications occurred. Postoperative complications include retroprosthetic membrane formation (47.6%), cystoid macular edema (33.3%), elevated intraocular pressure (23.8%), glaucoma progression (14.3%), and endophthalmitis (4.8%). The initial keratoprosthesis was retained in 19 eyes (90.5%). Conclusion: The Boston keratoprosthesis, based on early follow-up, is a good alternative as a primary penetrating corneal procedure in a select group of patients with very poor prognosis for penetrating keratoplasty. Although complications can occur and require close monitoring, visual acuity significantly improved in the majority of patients.

Original languageEnglish (US)
Pages (from-to)1436-1440
Number of pages5
JournalCornea
Volume31
Issue number12
DOIs
StatePublished - Dec 2012
Externally publishedYes

Fingerprint

Visual Acuity
Aniridia
Stevens-Johnson Syndrome
Penetrating Keratoplasty
Endophthalmitis
Corneal Transplantation
Macular Edema
Intraoperative Complications
Intraocular Pressure
Glaucoma
Fingers
Hot Temperature
Light
Membranes
Wounds and Injuries

Keywords

  • Boston keratoprosthesis
  • limbal stem cell deficiency
  • penetrating keratoplasty

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure. / Kang, Joann J.; De La Cruz, Jose; Cortina, Maria Soledad.

In: Cornea, Vol. 31, No. 12, 12.2012, p. 1436-1440.

Research output: Contribution to journalArticle

Kang, Joann J. ; De La Cruz, Jose ; Cortina, Maria Soledad. / Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure. In: Cornea. 2012 ; Vol. 31, No. 12. pp. 1436-1440.
@article{3ad9f9b2a33a4d0a8c113edea7ac0213,
title = "Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure",
abstract = "Purpose: To report the short-term visual outcomes and complications of keratoprosthesis surgery as the primary penetrating corneal procedure for patients at high risk for conventional corneal transplantation. Methods: A retrospective chart review was conducted of 21 eyes of 19 patients who underwent either Boston keratoprosthesis type I or type II as the primary penetrating corneal procedure from February 2007 to March 2011. Results: Nineteen type I (90.5{\%}) and 2 type II (9.5{\%}) Boston keratoprosthesis procedures were performed in 19 patients. Mean follow-up was 14.6 months (range, 6-36.3 mo). Primary indications for surgery included chemical or thermal injury, aniridia, and Stevens-Johnson syndrome. Preoperative best-corrected visual acuity (BCVA) ranged from 20/100 to light perception and was count fingers or worse in 20 eyes (95.2{\%}). At last follow-up for all eyes, 15 eyes (71.4{\%}) achieved BCVA ≥ 20/200 and 4 eyes (19{\%}) improved to BCVA ≥ 20/50. No intraoperative complications occurred. Postoperative complications include retroprosthetic membrane formation (47.6{\%}), cystoid macular edema (33.3{\%}), elevated intraocular pressure (23.8{\%}), glaucoma progression (14.3{\%}), and endophthalmitis (4.8{\%}). The initial keratoprosthesis was retained in 19 eyes (90.5{\%}). Conclusion: The Boston keratoprosthesis, based on early follow-up, is a good alternative as a primary penetrating corneal procedure in a select group of patients with very poor prognosis for penetrating keratoplasty. Although complications can occur and require close monitoring, visual acuity significantly improved in the majority of patients.",
keywords = "Boston keratoprosthesis, limbal stem cell deficiency, penetrating keratoplasty",
author = "Kang, {Joann J.} and {De La Cruz}, Jose and Cortina, {Maria Soledad}",
year = "2012",
month = "12",
doi = "10.1097/ICO.0b013e31823f7765",
language = "English (US)",
volume = "31",
pages = "1436--1440",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure

AU - Kang, Joann J.

AU - De La Cruz, Jose

AU - Cortina, Maria Soledad

PY - 2012/12

Y1 - 2012/12

N2 - Purpose: To report the short-term visual outcomes and complications of keratoprosthesis surgery as the primary penetrating corneal procedure for patients at high risk for conventional corneal transplantation. Methods: A retrospective chart review was conducted of 21 eyes of 19 patients who underwent either Boston keratoprosthesis type I or type II as the primary penetrating corneal procedure from February 2007 to March 2011. Results: Nineteen type I (90.5%) and 2 type II (9.5%) Boston keratoprosthesis procedures were performed in 19 patients. Mean follow-up was 14.6 months (range, 6-36.3 mo). Primary indications for surgery included chemical or thermal injury, aniridia, and Stevens-Johnson syndrome. Preoperative best-corrected visual acuity (BCVA) ranged from 20/100 to light perception and was count fingers or worse in 20 eyes (95.2%). At last follow-up for all eyes, 15 eyes (71.4%) achieved BCVA ≥ 20/200 and 4 eyes (19%) improved to BCVA ≥ 20/50. No intraoperative complications occurred. Postoperative complications include retroprosthetic membrane formation (47.6%), cystoid macular edema (33.3%), elevated intraocular pressure (23.8%), glaucoma progression (14.3%), and endophthalmitis (4.8%). The initial keratoprosthesis was retained in 19 eyes (90.5%). Conclusion: The Boston keratoprosthesis, based on early follow-up, is a good alternative as a primary penetrating corneal procedure in a select group of patients with very poor prognosis for penetrating keratoplasty. Although complications can occur and require close monitoring, visual acuity significantly improved in the majority of patients.

AB - Purpose: To report the short-term visual outcomes and complications of keratoprosthesis surgery as the primary penetrating corneal procedure for patients at high risk for conventional corneal transplantation. Methods: A retrospective chart review was conducted of 21 eyes of 19 patients who underwent either Boston keratoprosthesis type I or type II as the primary penetrating corneal procedure from February 2007 to March 2011. Results: Nineteen type I (90.5%) and 2 type II (9.5%) Boston keratoprosthesis procedures were performed in 19 patients. Mean follow-up was 14.6 months (range, 6-36.3 mo). Primary indications for surgery included chemical or thermal injury, aniridia, and Stevens-Johnson syndrome. Preoperative best-corrected visual acuity (BCVA) ranged from 20/100 to light perception and was count fingers or worse in 20 eyes (95.2%). At last follow-up for all eyes, 15 eyes (71.4%) achieved BCVA ≥ 20/200 and 4 eyes (19%) improved to BCVA ≥ 20/50. No intraoperative complications occurred. Postoperative complications include retroprosthetic membrane formation (47.6%), cystoid macular edema (33.3%), elevated intraocular pressure (23.8%), glaucoma progression (14.3%), and endophthalmitis (4.8%). The initial keratoprosthesis was retained in 19 eyes (90.5%). Conclusion: The Boston keratoprosthesis, based on early follow-up, is a good alternative as a primary penetrating corneal procedure in a select group of patients with very poor prognosis for penetrating keratoplasty. Although complications can occur and require close monitoring, visual acuity significantly improved in the majority of patients.

KW - Boston keratoprosthesis

KW - limbal stem cell deficiency

KW - penetrating keratoplasty

UR - http://www.scopus.com/inward/record.url?scp=84870240110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870240110&partnerID=8YFLogxK

U2 - 10.1097/ICO.0b013e31823f7765

DO - 10.1097/ICO.0b013e31823f7765

M3 - Article

C2 - 22367042

AN - SCOPUS:84870240110

VL - 31

SP - 1436

EP - 1440

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 12

ER -